Piper Sandler Downgrades Rapt Therapeutics (RAPT) to Neutral

November 11, 2024 3:10 PM

Piper Sandler analyst Edward Tenthoff downgraded Rapt Therapeutics (NASDAQ: RAPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found